The mission of LLS is to cure leukemia, lymphoma, Hodgkin's Disease and myeloma, and improve the quality of patients and their families.
LS research investment has played a critical role in advancing therapies for blood cancer patients, including targeted and immunotherapies.
As there are no means of preventing or early screening for most blood cancers, the LLS research agenda is focused on finding cures. LLS funds research grants to support every discipline in the blood cancers. They partner directly with biotechnology companies to accelerate therapies. LLS has invested over 1 billion dollars in cancer research!
Despite their progress to date, blood cancer still kills people.
But thanks to promising LLS funded research in the field and on the horizon, we have a real opportunity to change that outcome. With continued support, the thousands of patients who don't respond to current treatments will have new and potentially better tolerated treatment options.
And we can ensure that patients get better access to life-saving treatments and therapies and quality of life.